In the last trading session, 1.07 million shares of the Anavex Life Sciences Corporation (NASDAQ:AVXL) were traded, and its beta was 0.78. Most recently the company’s share price was $9.56, and it changed around -$0.05 or -0.52% from the last close, which brings the market valuation of the company to $813.22M. AVXL currently trades at a discount to its 52-week high of $14.44, offering almost -51.05% off that amount. The share price’s 52-week low was $3.25, which indicates that the current value has risen by an impressive 66.0% since then. We note from Anavex Life Sciences Corporation’s average daily trading volume that its 10-day average is 1.07 million shares, with the 3-month average coming to 1.50 million.
Anavex Life Sciences Corporation stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended AVXL as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Anavex Life Sciences Corporation is expected to report earnings per share of -0.16 for the current quarter.
Anavex Life Sciences Corporation (NASDAQ:AVXL) trade information
Instantly AVXL has showed a red trend with a performance of -0.52% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 10.20 on recent trading dayincreased the stock’s daily price by 6.27%. The company’s shares are currently down -10.99% year-to-date, but still up 2.69% over the last five days. On the other hand, Anavex Life Sciences Corporation (NASDAQ:AVXL) is 15.74% up in the 30-day period. We can see from the shorts that 23.44 million shares have been sold at a short interest cover period of 22.63 day(s).
The consensus price target as assigned by Wall Street analysts is $11, which translates to bulls needing to increase their stock price by 13.09% from its current value. Analyst projections state that AVXL is forecast to be at a low of $11 and a high of $11.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 0.85%.
AVXL Dividends
Anavex Life Sciences Corporation’s next quarterly earnings report is expected to be released on 2025-Feb-11.
Anavex Life Sciences Corporation (NASDAQ:AVXL)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 3.04% of Anavex Life Sciences Corporation shares, and 35.16% of them are in the hands of institutional investors. The stock currently has a share float of 36.27%. Anavex Life Sciences Corporation stock is held by 217.0 institutions, with BLACKROCK INC. being the largest institutional investor. By 2024-06-30, it held 7.5607% of the shares, which is about 6.39 million shares worth $26.97 million.
VANGUARD GROUP INC, with 5.5154% or 4.55 million shares worth $19.19 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Dec 31, 2024 . The former held 2.53 shares worth $24.23 million, making up 2.98% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 2.04 shares worth around $19.52 million, which represents about 2.40% of the total shares outstanding.
